We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+8.42%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$160M
AUM Growth
+$19.5M
Cap. Flow
+$10.9M
Cap. Flow %
6.8%
Top 10 Hldgs %
27.73%
Holding
76
New
19
Increased
19
Reduced
25
Closed
10

Sector Composition

Rank Sector Weight
1 Healthcare 89.14%
2 Financials 2.09%
3 Industrials 0.78%
4 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVHC
26
DELISTED
Envision Healthcare Holdings Inc
EVHC
$2.71M 1.69%
+26,720
New +$2.67M
VTRS icon
27
Viatris
VTRS
$18.8B
$2.69M 1.68%
+55,000
New +$2.67M
CVS icon
28
CVS Health
CVS
$119B
$2.6M 1.63%
34,780
-15,220
-30% -$1.08M
ACH
29
Accendra Health
ACH
$93.4M
$2.42M 1.51%
+68,940
New +$2.43M
BSX icon
30
Boston Scientific
BSX
$74.4B
$2.39M 1.49%
176,950
-23,050
-12% -$303K
FRX
31
DELISTED
FOREST LABORATORIES INC
FRX
$2.31M 1.44%
25,000
-25,000
-50% -$2.02M
DGX icon
32
Quest Diagnostics
DGX
$26.3B
$2.23M 1.39%
+38,532
New +$2.07M
COV
33
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$2.21M 1.38%
+30,000
New +$2.09M
HSP
34
DELISTED
HOSPIRA INC
HSP
$2.16M 1.35%
50,000
+10,000
+25% +$429K
BIIB icon
35
Biogen
BIIB
$30.4B
$2.14M 1.34%
7,000
-3,000
-30% -$952K
UAM
36
DELISTED
Universal American Corp
UAM
$2.12M 1.32%
300,000
+267,375
+820% +$1.9M
REGN icon
37
Regeneron Pharmaceuticals
REGN
$83.1B
$2.1M 1.31%
+7,000
New +$2.16M
AGN
38
DELISTED
Allergan plc
AGN
$2.06M 1.29%
10,000
-3,000
-23% -$594K
RVTY icon
39
Revvity
RVTY
$13B
$2.03M 1.27%
45,000
-15,000
-25% -$658K
BRKR icon
40
Bruker
BRKR
$8.7B
$2.02M 1.26%
88,400
+18,400
+26% +$401K
SCAI
41
DELISTED
Surgical Care Affiliates, Inc.
SCAI
$1.96M 1.23%
+63,872
New +$2.06M
STJ
42
DELISTED
St Jude Medical
STJ
$1.96M 1.22%
30,000
-10,000
-25% -$651K
A icon
43
Agilent Technologies
A
$42.4B
$1.96M 1.22%
48,930
-20,970
-30% -$864K
TRNX
44
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$1.91M 1.19%
90,000
-19,000
-17% -$369K
MNK
45
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$1.87M 1.17%
29,510
-490
-2% -$30.9K
TMO icon
46
Thermo Fisher Scientific
TMO
$224B
$1.8M 1.13%
15,000
-15,000
-50% -$1.78M
GILD icon
47
Gilead Sciences
GILD
$169B
$1.77M 1.11%
25,000
-20,000
-44% -$1.57M
CPHD
48
DELISTED
Cepheid Inc
CPHD
$1.55M 0.97%
30,000
ILMN icon
49
Illumina
ILMN
$29B
$1.49M 0.93%
+10,280
New +$1.51M
ENDP
50
DELISTED
Endo International plc
ENDP
$1.37M 0.86%
20,000
-10,000
-33% -$709K

Similar funds

Sivik Global Healthcare's Q1 2014 Portfolio in Review

As of Q1 2014, Sivik Global Healthcare held 76 positions worth $160M, up 14% from $141M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Sivik Global Healthcare deployed $10.9M of net new capital in Q1 2014, opening 19 new positions and adding to 19 existing holdings. Its largest new stake was Elevance Health: 34,670 shares worth $3.45M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 87% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was MEDIVATION, INC., an estimated $2.21M trimmed.

  • Sivik Global Healthcare's largest Q1 2014 buy was Elevance Health: 34,670 shares worth $3.45M.
  • Sivik Global Healthcare added most to Universal American Corp in Q1 2014, an estimated $1.9M increase.
  • Sivik Global Healthcare's biggest Q1 2014 reduction was MEDIVATION, INC., cutting an estimated $2.21M.
  • Sivik Global Healthcare fully exited Express Scripts Holding Company in Q1 2014, selling an estimated $3.14M.
  • Sivik Global Healthcare's ten largest holdings make up 28% of its $160M portfolio in Q1 2014.
  • Sivik Global Healthcare opened 19 new positions and closed 10 in Q1 2014.
  • Sivik Global Healthcare's portfolio value rose 14% quarter-over-quarter to $160M.

Based on Sivik Global Healthcare's 13F filing for Q1 2014, filed 10 Apr 2014.